Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 1,716 | 2,378 | 1,795 | 1,432 | 925 |
| Cost of Goods | 649 | 617 | 525 | 411 | 241 |
| Gross Profit | 1,067 | 1,761 | 1,270 | 1,021 | 684 |
| Operating Expenses | 6,296 | 6,676 | 6,346 | 4,849 | 4,751 |
| Operating Income | -4,580 | -4,299 | -4,551 | -3,417 | -3,826 |
| Interest Expense | 137 | 195 | 128 | 77 | 177 |
| Other Income | -9,815 | -3 | 21 | 47 | 4,551 |
| Pre-tax Income | -14,532 | -4,496 | -4,658 | -3,447 | 548 |
| Net Income Continuous | -14,532 | -4,496 | -4,658 | -3,447 | 548 |
| Net Income | $-14,532 | $-4,496 | $-4,658 | $-3,447 | $548 |
| EPS Basic Total Ops | -60.00 | -100.00 | -144.00 | -392.00 | 8,490.00 |
| EPS Basic Continuous Ops | -61.52 | -99.24 | -143.82 | -391.65 | 8,490.60 |
| EPS Diluted Total Ops | -60.00 | -100.00 | -144.00 | -392.00 | 8,490.00 |
| EPS Diluted Continuous Ops | -61.52 | -99.24 | -143.82 | -391.65 | 8,490.60 |
| EBITDA(a) | $-3,827 | $-3,555 | $-3,877 | $-2,861 | $-3,210 |